| Followers | 141 |
| Posts | 5785 |
| Boards Moderated | 0 |
| Alias Born | 06/09/2020 |
Sunday, April 25, 2021 8:35:02 AM
I have a draft up now regarding the patent and rights discussions we've had and with the ATLnsider / Adam Feuerstein discussion added as "a starter". I only changed slightly in peoples comments and only if i've felt there's been some statements, that didn't fit in the narrative, like commenting on another posting, which would feel out of place suddenly.
I've saved it in Word DOCX format and everyone can view it (5 MB)
https://drive.google.com/file/d/1rMkBbniY3z1u0zLw84XUsCpIdZG6ZW1A/view?usp=sharing
And in Google Docs format, also with everyone allowed to view.
https://docs.google.com/document/d/1C_adJHFM-zaLN73oAfBH778vJHw6I2fJ2BayDe0sB28/edit?usp=sharing
Hope it can be of help, and if people would like to brush it up, mail me or get editor rights for it.
flemming.kristensen@gmail.com
I've saved it in Word DOCX format and everyone can view it (5 MB)
https://drive.google.com/file/d/1rMkBbniY3z1u0zLw84XUsCpIdZG6ZW1A/view?usp=sharing
And in Google Docs format, also with everyone allowed to view.
https://docs.google.com/document/d/1C_adJHFM-zaLN73oAfBH778vJHw6I2fJ2BayDe0sB28/edit?usp=sharing
Hope it can be of help, and if people would like to brush it up, mail me or get editor rights for it.
flemming.kristensen@gmail.com
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
